Design principles for bifunctional targeted oligonucleotide enhancers of splicing
Design principles for bifunctional targeted oligonucleotide enhancers of splicing
Controlling the patterns of splicing of specific genes is an important goal in the development of new therapies. We have shown that the splicing of a refractory exon, SMN2 exon 7, could be increased in fibroblasts derived from patients with spinal muscular atrophy by using bifunctional targeted oligonucleotide enhancers of splicing (TOES) oligonucleotides that anneal to the exon and contain a 'tail' of enhancer sequences that recruit activating proteins. We show here that there are striking agreements between the effects of oligonucleotides on splicing in vitro and on both splicing and SMN2 protein expression in patient-derived fibroblasts, indicating that the effects on splicing are the major determinant of success. Increased exon inclusion depends on the number, sequence and chemistry of the motifs that bind the activator protein SRSF1, but it is not improved by increasing the strength of annealing to the target site. The optimal oligonucleotide increases protein levels in transfected fibroblasts by a mean value of 2.6-fold (maximum 4.6-fold), and after two rounds of transfection the effect lasted for a month. Oligonucleotides targeted to the upstream exon (exon 6 in SMN) are also effective. We conclude that TOES oligonucleotides are highly effective reagents for restoring the splicing of refractory exons and can act across long introns.
Base Sequence, Binding Sites, Cell Line, Exons, Humans, Kinetics, Nuclear Proteins, Oligonucleotides, RNA Splicing, RNA-Binding Proteins, Serine-Arginine Splicing Factors, Survival of Motor Neuron 2 Protein, Journal Article, Research Support, Non-U.S. Gov't
7194-208
Owen, Nicholas
77e761e3-c206-4065-8587-5079703a4a47
Zhou, Haiyan
e5482e8b-6b0c-468a-81df-c5c60b73aba3
Malygin, Alexey A.
69dc1097-5292-4f30-9af0-8a480ee1b71d
Sangha, Jason
abd39c11-12cd-48a9-8961-df7fc41a3791
Smith, Lindsay D.
1d44c2d0-d5af-411e-b6cd-9b5633f2eb1e
Muntoni, Francesco
24b9757d-8a5b-4532-94f6-6d25ba539ee7
Eperon, Ian C.
ded0b4c2-da7f-4de2-814b-13a30d0202ee
1 September 2011
Owen, Nicholas
77e761e3-c206-4065-8587-5079703a4a47
Zhou, Haiyan
e5482e8b-6b0c-468a-81df-c5c60b73aba3
Malygin, Alexey A.
69dc1097-5292-4f30-9af0-8a480ee1b71d
Sangha, Jason
abd39c11-12cd-48a9-8961-df7fc41a3791
Smith, Lindsay D.
1d44c2d0-d5af-411e-b6cd-9b5633f2eb1e
Muntoni, Francesco
24b9757d-8a5b-4532-94f6-6d25ba539ee7
Eperon, Ian C.
ded0b4c2-da7f-4de2-814b-13a30d0202ee
Owen, Nicholas, Zhou, Haiyan, Malygin, Alexey A., Sangha, Jason, Smith, Lindsay D., Muntoni, Francesco and Eperon, Ian C.
(2011)
Design principles for bifunctional targeted oligonucleotide enhancers of splicing.
Nucleic Acids Research, 39 (16), .
(doi:10.1093/nar/gkr152).
Abstract
Controlling the patterns of splicing of specific genes is an important goal in the development of new therapies. We have shown that the splicing of a refractory exon, SMN2 exon 7, could be increased in fibroblasts derived from patients with spinal muscular atrophy by using bifunctional targeted oligonucleotide enhancers of splicing (TOES) oligonucleotides that anneal to the exon and contain a 'tail' of enhancer sequences that recruit activating proteins. We show here that there are striking agreements between the effects of oligonucleotides on splicing in vitro and on both splicing and SMN2 protein expression in patient-derived fibroblasts, indicating that the effects on splicing are the major determinant of success. Increased exon inclusion depends on the number, sequence and chemistry of the motifs that bind the activator protein SRSF1, but it is not improved by increasing the strength of annealing to the target site. The optimal oligonucleotide increases protein levels in transfected fibroblasts by a mean value of 2.6-fold (maximum 4.6-fold), and after two rounds of transfection the effect lasted for a month. Oligonucleotides targeted to the upstream exon (exon 6 in SMN) are also effective. We conclude that TOES oligonucleotides are highly effective reagents for restoring the splicing of refractory exons and can act across long introns.
This record has no associated files available for download.
More information
Accepted/In Press date: 1 March 2011
e-pub ahead of print date: 20 May 2011
Published date: 1 September 2011
Keywords:
Base Sequence, Binding Sites, Cell Line, Exons, Humans, Kinetics, Nuclear Proteins, Oligonucleotides, RNA Splicing, RNA-Binding Proteins, Serine-Arginine Splicing Factors, Survival of Motor Neuron 2 Protein, Journal Article, Research Support, Non-U.S. Gov't
Identifiers
Local EPrints ID: 420383
URI: http://eprints.soton.ac.uk/id/eprint/420383
ISSN: 0305-1048
PURE UUID: 798f175b-bff6-4269-b162-c2a0437ca924
Catalogue record
Date deposited: 04 May 2018 16:30
Last modified: 15 Mar 2024 19:32
Export record
Altmetrics
Contributors
Author:
Nicholas Owen
Author:
Haiyan Zhou
Author:
Alexey A. Malygin
Author:
Jason Sangha
Author:
Lindsay D. Smith
Author:
Francesco Muntoni
Author:
Ian C. Eperon
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics